Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Ascentage-Pharma-form

More Like This

PR Newswire associated0

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda

PR Newswire associated0

Esentia Announces Confidential Submission of Draft Registration Statement to SEC for Proposed Initial Public Offering in the U.S.

PR Newswire associated0

Via announces confidential submission of draft registration statement related to proposed public offering

PR Newswire associated0

Blockchain.com Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of Class A Ordinary Shares

Business Wire logo

Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares

PR Newswire associated0

Assaí Announces Intention to File a Form 15F to Deregister in the United States under the U.S. Securities Exchange Act of 1934

PR Newswire associated0

Gemini Announces Confidential Submission of Draft Registration Statement for a Proposed Initial Public Offering

CZECHOSLOVAK GROUP announces planned IPO